CORE Chiropractic Voted Best Chiropractor for the 4th Consecutive Year
United States, August 2, 2025 -- CORE Chiropractic, a top-rated Houston chiropractic office, is delighted to announce it has, for the fourth time in a row, been awarded the prestigious Best Chiropracto r award by the Houston Chronicle. The award recognizes CORE Chiropractic's outstanding contributions to chiropractic care and its team's commitment to providing exceptional patient care. It is one of several accolades the clinic has accumulated this year.
Besides celebrating receiving the Best Chiropractor award, CORE Chiropractic is also celebrating another win: the Best Alternative Pain Management award, also given by the Houston Chronicle. The Houston chiropractor has won in this new category for two consecutive years, marking six straight appearances in the Houston Chronicle's Best of the Best Award list. However, CORE Chiropractic has not only been recognized as the best chiropractic office by Houston Chronicle, the clinic has also earned awards from ThreeBest Rated, Living Magazine's Best of, and H Town Best.
The accolades celebrate CORE Chiropractic's dedication to delivering client-focused, results-driven chiropractic care, from X-ray guided chiropractic methods to modern therapies, ensuring every client receives personalized, high-quality care. The clinic's consistency in integrating its unique CORE system approach to chiropractic care and fostering a patient-friendly environment for better patient outcomes has set it apart as one of the best Houston chiropractors.
'We are deeply honored to receive this prestigious award,' said Dr. Philip Cordova. 'This recognition reflects our collective passion and the dedication to outstanding customer service our team possesses. Our mission is to provide consistent, fast, and lasting relief and this award streak inspires to continue striving for excellence in everything we do.'
CORE Chiropractic's awards acknowledge its advanced chiropractic services and therapies, including spinal decompression therapy, Pulsed Electro Magnetic Field Therapy (PEMF), and High Energy Inductive Therapy (HEIT). By specializing in chiropractic care that addresses neck and back pain, sciatica, muscle strains, disc injuries, and other injuries, the clinic continues to establish itself as the leader in precision methods that ensure patient comfort. CORE Chiropractic is also widely recognized for its comprehensive approach, which involves educating patients on chiropractic care so that they can make informed decisions.
The clinic's services and commitment to customer service have significantly impacted chiropractic care in Houston. With these awards, CORE Chiropractic reaffirms its focus on addressing the root cause of pain without drugs or surgery, only chiropractic care.
In celebration of these prestigious achievements, CORE Chiropractic has announced that it will open its third location in Memorial City in January 2026. Dr. Natalie Cordova shared that with the new location, CORE Chiropractic looks forward to continuing its award streak by delivering unmatched services using the latest technology and chiropractic practices.
'We are not slowing down. Our awards and expansion are a testament to our leadership in chiropractic care in Houston. This new location will ensure we expand access to our services and remain at the forefront of chiropractic care, providing patients across Houston with the highest level of service.'
For more information, visit CORE Chiropractic.
Contact Info:
Name: Philip Cordova DC
Email: Send Email
Organization: CORE Chiropractic
Phone: 7136223300
Website: https://www.corechiropractic.net
Release ID: 89165916
If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
QuidelOrtho (QDEL) Q2 Earnings Report Preview: What To Look For
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be reporting results this Tuesday afternoon. Here's what you need to know. QuidelOrtho met analysts' revenue expectations last quarter, reporting revenues of $692.8 million, down 2.6% year on year. It was a mixed quarter for the company, with a solid beat of analysts' EPS estimates but a slight miss of analysts' full-year EPS guidance estimates. Is QuidelOrtho a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting QuidelOrtho's revenue to decline 4.1% year on year to $611 million, in line with the 4.2% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.01 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. QuidelOrtho has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 4.2% on average. Looking at QuidelOrtho's peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. GE HealthCare delivered year-on-year revenue growth of 3.5%, beating analysts' expectations by 1%, and Hologic reported revenues up 1.2%, topping estimates by 1.7%. GE HealthCare traded down 8.3% following the results while Hologic was up 2.9%. Read our full analysis of GE HealthCare's results here and Hologic's results here. Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the healthcare equipment and supplies stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. QuidelOrtho is down 21.9% during the same time and is heading into earnings with an average analyst price target of $47.14 (compared to the current share price of $22.81). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
19 minutes ago
- Yahoo
agilon health (AGL) Q2 Earnings: What To Expect
Healthcare services company Agilon Health (NYSE:AGL) will be announcing earnings results this Tuesday after the bell. Here's what to look for. agilon health beat analysts' revenue expectations by 1.8% last quarter, reporting revenues of $1.53 billion, down 4.5% year on year. It was a slower quarter for the company, with a significant miss of analysts' EPS estimates and EBITDA guidance for next quarter missing analysts' expectations significantly. It lost -36,000 customers and ended up with a total of 491,000. Is agilon health a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting agilon health's revenue to be flat year on year at $1.47 billion, slowing from the 38.7% increase it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.11 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. agilon health has missed Wall Street's revenue estimates five times over the last two years. Looking at agilon health's peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Select Medical delivered year-on-year revenue growth of 4.5%, meeting analysts' expectations, and CVS Health reported revenues up 8.4%, topping estimates by 5.1%. Select Medical traded down 15.1% following the results while CVS Health's stock price was unchanged. Read our full analysis of Select Medical's results here and CVS Health's results here. Debates around the economy's health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. agilon health is down 25.8% during the same time and is heading into earnings with an average analyst price target of $3.59 (compared to the current share price of $1.73). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CBS News
an hour ago
- CBS News
Mothers and injured children evacuate Gaza, arrive in Texas for critical medical care amid war chaos
With the ongoing war, Gaza is one of the most difficult places in the world to get in or out of, but two Palestinian mothers and their young, injured sons are fortunate to be on Texas soil Sunday night. They are evacuees from Gaza who arrived at DFW Airport this afternoon in front of a large crowd of well-wishers. There were Palestinian flags and welcoming signs carried by dozens of people who wrapped around the doors for DFW Airport's international arrivals when two families walked through to cheers and chants. "She said the first feeling she got was a feeling of safety," said Nisreen Hajaj, with HEAL Palestine, who translated. It's a journey that got the young mother out of harm's way in Gaza as well as another, whose translator says she had to leave other children behind and has lost an extraordinary number of relatives since the war began. The two injured boys are in Texas to receive treatment that would be impossible back home. Anwar is 14 years old and on crutches after losing part of a leg while fleeing an air strike. Zuhair is 6 years old and has severe injuries from a bomb that his mother says destroyed their family's home. "He has an injury to his hand and unfortunately, an injury to his abdomen as well," said Hajaj. These two children are among 11 who arrived at airports on Sunday across the U.S. with no date set to return. From DFW, it's off to San Antonio for these mothers, where they will stay with host families while their children receive free medical treatment through the organization HEAL Palestine. "We are sitting by TV screens all day watching this unfold in front of her eyes, feeling helpless of not being able to do anything to stop the war," said Hajaj. "This is the message that we want to get across that this is not these children's fault." The organization has helped 30 injured children since the beginning of the war to get the help they need here in America. In some cases, like Anwar's, it may be prosthetics, or even further amputations. A young boy, who's been through so much, but still managed a smile on his way, hopefully to a better life.
